Have a personal or library account? Click to login
The FORS awakens: review of a blood group system reborn Cover

The FORS awakens: review of a blood group system reborn

By: A.K. Hult and  M.L. Olsson  
Paid access
|Oct 2019

References

  1. Landsteiner K. Zur Kenntnis der antifermentativen, lytischen und agglutinierenden Wirkungen des Blutserums und der Lymphe. Zbl Bakt 1900;27:357–62.
  2. Landsteiner K. Über Agglutinationserscheinungen normalen Menschlichen Blutes. Wiener Klinische Wochenschrift 1901;14:1132–4.
  3. Kabat EA. Blood group substances: their chemistry and immunohistochemistry. New York: Academic Press, 1956.
  4. Morgan WT, Watkins WM. Some aspects of the biochemistry of the human blood-group substances. Br Med Bull 1959;15:109– 13.10.1093/oxfordjournals.bmb.a069732
  5. Varki A. Essentials of glycobiology. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2009.
  6. Gagneux P, Varki A. Evolutionary considerations in relating oligosaccharide diversity to biological function. Glycobiology 1999;9:747–55.10.1093/glycob/9.8.747
  7. Neil SJ, McKnight A, Gustafsson K, Weiss RA. HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation. Blood 2005; 105:4693–9.10.1182/blood-2004-11-4267
  8. Preece AF, Strahan KM, Devitt J, Yamamoto F, Gustafsson K. Expression of ABO or related antigenic carbohydrates on viral envelopes leads to neutralization in the presence of serum containing specific natural antibodies and complement. Blood 2002;99:2477–82.10.1182/blood.V99.7.2477
  9. Dixon FJ Jr, Humphrey JH (eds). Advances in immunology. San Diego, CA: Academic Press, 1963:351.
  10. Forssman J. Die Herstellung hochwertiger spezifisher Schafhämolysin ohne Verwendung von Schaftblut: Ein Beitrag Zur Lehre von heterolofer Antikörperbildung. Biochem Zeit 1911;37:78–115.
  11. Leduc EH, Tanaka N. A study of the cellular distribution of Forssman antigen in various species. J Immunol 1956;77:198– 212.
  12. Hakomori S, Wang SM, Young WW Jr. Isoantigenic expression of Forssman glycolipid in human gastric and colonic mucosa: its possible identity with "A-like antigen" in human cancer. Proc Natl Acad Sci U S A 1977;74:3023–7.10.1073/pnas.74.7.3023
  13. Kawanami J. The appearance of Forssman hapten in human tumor. J Biochem 1972;72:783–5.10.1093/oxfordjournals.jbchem.a129960
  14. Mori E, Mori T, Sanai Y, Nagai Y. Radioimmuno-thin-layer chromatographic detection of Forssman antigen in human carcinoma cell lines. Biochem Biophys Res Commun 1982;108:926–32.10.1016/0006-291X(82)92087-3
  15. Uemura K, Hattori H, Ono K, Ogata H, Taketomi T. Expression of Forssman glycolipid and blood group-related antigens A, Le(x), and Le(y) in human gastric cancer and in fetal tissues. Jpn J Exp Med 1989;59:239–49.
  16. Ono K, Hattori H, Uemura K, Nakayama J, Ota H, Katsuyama T. Expression of Forssman antigen in human large intestine. J Histochem Cytochem 1994;42:659–65.10.1177/42.5.7512587
  17. Yokota M, Warner GA, Hakomori S. Blood group A–like glycolipid and a novel Forssman antigen in the hepatocarcinoma of a blood group O individual. Cancer Res 1981;41:4185–90.
  18. Breimer M. Chemical and immunological identification of the Forssman pentaglycosylceramide in human kidney. Glycoconj J 1985;2:375–85.
  19. Siddiqui B, Hakomori S. A revised structure for the Forssman glycolipid hapten. J Biol Chem 1971;246:5766–9.10.1016/S0021-9258(18)61871-X
  20. Karlsson KA, Leffler H, Samuelsson BE. Characterization of the Forssman glycolipid hapten of horse kidney by mass spectrometry. J Biol Chem 1974;249:4819–23.10.1016/S0021-9258(19)42394-6
  21. Moore TL, Dorner RW. 19S IgM Forssman-type heterophile antibodies in juvenile rheumatoid arthritis. Arthritis Rheum 1980;23:1262–7.10.1002/art.1780231106
  22. Ilyas AA, Mithen FA, Chen ZW, Cook SD. Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barre syndrome. J Neurol Sci 1991;102:67–75.10.1016/0022-510X(91)90095-O
  23. Ariga T, Yoshida T, Mimori T, Yu RK. Autoantibodies against Forssman glycolipids in Graves’ disease and Hashimoto’s thyroiditis. Clin Exp Immunol 1991;86:483–8.10.1111/j.1365-2249.1991.tb02957.x
  24. Brouard S, Bouhours D, Sebille F, Menoret S, Soulillou JP, Vanhove B. Induction of anti-Forssman antibodies in the hamster-to-rat xenotransplantation model. Transplantation 2000;69:1193–201.10.1097/00007890-200003270-00026
  25. Gustavsson ML, Johnsson C, Albertsson P, et al. Characterization of Forssman and other antigen/antibody systems in vascularized mouse heart to rat xenotransplantation. Scand J Immunol 2001;53:121–31.10.1046/j.1365-3083.2001.00840.x
  26. Yeh P, Ezzelarab M, Bovin N, et al. Investigation of potential carbohydrate antigen targets for human and baboon antibodies. Xenotransplantation 2010;17:197–206.10.1111/j.1399-3089.2010.00579.x
  27. Storry JR, Castilho L, Daniels G, et al. International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology: Cancun report (2012). Vox Sang 2014;107:90–6.10.1111/vox.12127
  28. Stamps R, Sokol RJ, Leach M, Herron R, Smith G. A new variant of blood group A. Apae. Transfusion 1987;27:315–8.10.1046/j.1537-2995.1987.27487264737.x
  29. Issitt PD, Anstee DJ. Applied blood group serology. Miami, FL: Montgomery Scientific Publications, 1998.
  30. Svensson L, Hult AK, Stamps R, et al. Forssman expression on human erythrocytes: biochemical and genetic evidence of a new histo-blood group system. Blood 2013;121:1459–68.10.1182/blood-2012-10-455055
  31. Slomiany BL, Banas-Gruszka Z, Kojima K, Herp A, Slomiany A. The glycoprotein nature of Forssman antigen in dog gastric mucus. FEBS Lett 1981;130:201–4.10.1016/0014-5793(81)81119-2
  32. Cantarel BL, Coutinho PM, Rancurel C, Bernard T, Lombard V, Henrissat B. The Carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics. Nucleic Acids Res 2009;37:D233–8.10.1093/nar/gkn663
  33. Yamamoto F, Clausen H, White T, Marken J, Hakomori S. Molecular genetic basis of the histo-blood group ABO system. Nature 1990;345:229–33.10.1038/345229a0
  34. Koike C, Fung JJ, Geller DA, et al. Molecular basis of evolutionary loss of the alpha 1,3-galactosyltransferase gene in higher primates. J Biol Chem 2002;277:10114–20.10.1074/jbc.M110527200
  35. Galili U, Shohet SB, Kobrin E, Stults CL, Macher BA. Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem 1988;263:17755–62.10.1016/S0021-9258(19)77900-9
  36. Keusch JJ, Manzella SM, Nyame KA, Cummings RD, Baenziger JU. Expression cloning of a new member of the ABO blood group glycosyltransferases, iGb3 synthase, that directs the synthesis of isoglobo-glycosphingolipids. J Biol Chem 2000;275:25308–14.10.1074/jbc.M00262920010854427
  37. Xu H, Storch T, Yu M, Elliott SP, Haslam DB. Characterization of the human Forssman synthetase gene: an evolving association between glycolipid synthesis and host-microbial interactions. J Biol Chem 1999;274:29390–8.10.1074/jbc.274.41.2939010506200
  38. Yamamoto M, Cid E, Yamamoto F. Molecular genetic basis of the human Forssman glycolipid antigen negativity. Sci Rep 2012;2:975.10.1038/srep00975352116723240079
  39. Turcot-Dubois AL, Le Moullac-Vaidye B, Despiau S, et al. Long-term evolution of the CAZY glycosyltransferase 6 (ABO) gene family from fishes to mammals: a birth-and-death evolution model. Glycobiology 2007;17:516–28.10.1093/glycob/cwm01617298992
  40. Eirin-Lopez JM, Rebordinos L, Rooney AP, Rozas J. The birth-and-death evolution of multigene families revisited. Genome Dyn 2012;7:170–96.10.1159/00033711922759819
  41. Haslam DB, Baenziger JU. Expression cloning of Forssman glycolipid synthetase: a novel member of the histo-blood group ABO gene family. Proc Natl Acad Sci U S A 1996;93: 10697–702.10.1073/pnas.93.20.10697382178855242
  42. Elliott SP, Yu M, Xu H, Haslam DB. Forssman synthetase expression results in diminished shiga toxin susceptibility: a role for glycolipids in determining host–microbe interactions. Infect Immun 2003;71:6543–52.10.1128/IAI.71.11.6543-6552.200321958114573676
  43. NHLBI GO Exome Sequencing Project (ESP). Exome variant server. http://evs.gs.washington.edu/EVS/.
  44. Möller M, Jöud M, Storry JR, Olsson ML. Erythrogene: a database for in-depth analysis of the extensive variation in 36 blood group systems in the 1000 Genomes Project. Blood Adv 2016;1:240–9.10.1182/bloodadvances.2016001867573716829296939
  45. Barr K, Korchagina E, Popova I, Bovin N, Henry S. Monoclonal anti-A activity against the FORS1 (Forssman) antigen. Transfusion 2015;55:129–36.10.1111/trf.1277325039359
  46. Frame T, Carroll T, Korchagina E, Bovin N, Henry S. Synthetic glycolipid modification of red blood cell membranes. Transfusion 2007;47:876–882.10.1111/j.1537-2995.2007.01204.x17465953
  47. Springer GF, Horton RE. Blood group isoantibody stimulation in man by feeding blood group-active bacteria. J Clin Invest 1969;48:1280–91.10.1172/JCI1060943223514893685
  48. Young WW Jr, Hakomori SI, Levine P. Characterization of anti-Forssman (anti-Fs) antibodies in human sera: their specificity and possible changes in patients with cancer. J Immunol 1979;123:92–6.
  49. Strokan V, Rydberg L, Hallberg EC, Molne J, Breimer ME. Characterisation of human natural anti-sheep xenoantibodies. Xenotransplantation 1998;5:111–21.10.1111/j.1399-3089.1998.tb00017.x9584825
  50. Jesus C, Hesse C, Rocha C, et al. Prevalence of antibodies to a new histo-blood system: the FORS system. Blood Transfus 2016:1–6. doi: 10.2450/2016.0120-16.
  51. Boren T, Falk P, Roth KA, Larson G, Normark S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993;262:1892–5.10.1126/science.80181468018146
  52. Thorven M, Grahn A, Hedlund KO, et al. A homozygous nonsense mutation (428G-->A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J Virol 2005;79:15351–5.10.1128/JVI.79.24.15351-15355.2005131599816306606
  53. Vildevall M, Grahn A, Oliver SL, et al. Human antibody responses to bovine (Newbury-2) norovirus (GIII.2) and association to histo-blood group antigens. J Med Virol 2010;82:1241–6.10.1002/jmv.2177620513091
  54. Rowe JA, Handel IG, Thera MA, et al. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proc Natl Acad Sci U S A 2007;104:17471–6.10.1073/pnas.0705390104207728017959777
  55. Cserti CM, Dzik WH. The ABO blood group system and plasmodium falciparum malaria. Blood 2007;110:2250–8.10.1182/blood-2007-03-077602
  56. Wolofsky KT, Ayi K, Branch DR, et al. ABO blood groups influence macrophage-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes. PLoS Pathog 2012;8:e1002942.10.1371/journal.ppat.1002942
  57. Goel S, Palmkvist M, Moll K, et al. RIFINs are adhesins implicated in severe Plasmodium falciparum malaria. Nat Med 2015;21:314–7.10.1038/nm.3812
  58. Bock K, Breimer ME, Brignole A, et al. Specificity of binding of a strain of uropathogenic Escherichia coli to Gal alpha 1–4Gal-containing glycosphingolipids. J Biol Chem 1985;260: 8545–51.10.1016/S0021-9258(17)39507-8
  59. Muthing J, Meisen I, Zhang W, et al. Promiscuous Shiga toxin 2e and its intimate relationship to Forssman. Glycobiology 2012;22:849–62.10.1093/glycob/cws00922279060
  60. Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer 2015;15:540–55.10.1038/nrc398226289314
  61. Forbes SA, Beare D, Boutselakis H, et al. COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res 2017;45:D777–83.10.1093/nar/gkw1121521058327899578
  62. Yamamoto M, Cid E, Yamamoto F. Crosstalk between ABO and Forssman (FORS) blood group systems: FORS1 antigen synthesis by ABO gene-encoded glycosyltransferases. Sci Rep 2017;7:41632.10.1038/srep41632527855328134301
  63. Jacob F, Hitchins MP, Fedier A, et al. Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells. BMC Mol Biol 2014;15:24.10.1186/1471-2199-15-24419391025294702
DOI: https://doi.org/10.21307/immunohematology-2019-010 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 64 - 72
Published on: Oct 9, 2019
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 A.K. Hult, M.L. Olsson, published by American National Red Cross
This work is licensed under the Creative Commons License.